(19)
(11) EP 3 634 469 A1

(12)

(43) Date of publication:
15.04.2020 Bulletin 2020/16

(21) Application number: 18737034.1

(22) Date of filing: 09.06.2018
(51) International Patent Classification (IPC): 
A61K 38/28(2006.01)
C07K 16/40(2006.01)
A61K 39/395(2006.01)
A61K 39/00(2006.01)
(86) International application number:
PCT/IB2018/054182
(87) International publication number:
WO 2018/225041 (13.12.2018 Gazette 2018/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.06.2017 US 201762517672 P
13.07.2017 US 201762532162 P
04.05.2018 EP 18305565

(71) Applicant: Sanofi Biotechnology
75008 Paris (FR)

(72) Inventor:
  • BUJAS-BOBANOVIC, Maja
    75008 Paris (FR)

(74) Representative: Zwicker, Jörk 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) METHODS FOR TREATING HYPERLIPIDEMIA IN DIABETIC PATIENTS BY ADMINISTERING A PCSK9 INHIBITOR